Clinical Trial Detail

NCT ID NCT03709550
Title Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

prostate cancer

Therapies

Decitabine + Enzalutamide

Age Groups: adult senior

No variant requirements are available.